--- title: "Vertex Pharmaceuticals Currently Down Seven Consecutive Days, on Pace for Longest Losing Streak Since August 2021 — Data Talk" type: "News" locale: "en" url: "https://longbridge.com/en/news/292789554.md" description: "Vertex Pharmaceuticals (VRTX) is experiencing its longest losing streak since August 2021, with seven consecutive days of declines totaling a 10.34% drop. Trading at $474.81, the stock is on pace for its largest percentage decrease since July 2026 and has fallen from its all-time high of $529.59. Despite being down 4.41% month-to-date, it remains up 4.73% year-to-date." datetime: "2026-07-15T15:11:41.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/292789554.md) - [en](https://longbridge.com/en/news/292789554.md) - [zh-HK](https://longbridge.com/zh-HK/news/292789554.md) generator: "portal-rs" --- # Vertex Pharmaceuticals Currently Down Seven Consecutive Days, on Pace for Longest Losing Streak Since August 2021 — Data Talk Vertex Pharmaceuticals Incorporated (VRTX) is currently at $474.81, down $1.50 or 0.31% --Would be lowest close since June 23, 2026, when it closed at $468.42 --On pace for largest percent decrease since July 14, 2026, when it fell 0.82% --Currently down seven consecutive days; down 10.34% over this period --Longest losing streak since Aug. 16, 2021, when it fell for seven straight trading days --Worst seven day stretch since the seven days ending Aug. 13, 2025, when it fell 16.17% --Down 4.41% month-to-date --Up 4.73% year-to-date --Down 10.34% from its all-time closing high of $529.59 on July 6, 2026 --Up 1.12% from 52 weeks ago (July 16, 2025), when it closed at $469.55 --Down 10.34% from its 52-week closing high of $529.59 on July 6, 2026 --Up 29.54% from its 52-week closing low of $366.54 on Aug. 8, 2025 --Traded as low as $469.60; lowest intraday level since June 23, 2026, when it hit $463.76 --Down 1.41% at today's intraday low --10th least active stock in the Nasdaq 100 today All data as of 10:45:14 AM ET Source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires July 15, 2026 11:02 ET (15:02 GMT) Copyright (c) 2026 Dow Jones & Company, Inc. ### Related Stocks - [VRTX.US](https://longbridge.com/en/quote/VRTX.US.md) - [.NDX.US](https://longbridge.com/en/quote/.NDX.US.md) - [FDS.US](https://longbridge.com/en/quote/FDS.US.md) ## Related News & Research - [Clal Insurance Enterprises Holdings Ltd Buys Shares of 2,019 Vertex Pharmaceuticals Incorporated $VRTX](https://longbridge.com/en/news/296756674.md) - [The Bull Case For Vertex (VRTX) Could Change Following Upgraded 2026 Guidance And Pipeline Momentum - Learn Why](https://longbridge.com/en/news/296583461.md) - [Callan Family Office LLC Buys New Position in Vertex Pharmaceuticals Incorporated $VRTX](https://longbridge.com/en/news/296677120.md) - [Osmosis Investment Management UK Ltd Acquires Shares of 21,075 Vertex Pharmaceuticals Incorporated $VRTX](https://longbridge.com/en/news/296771760.md) - [TFR Capital LLC. Takes Position in Vertex Pharmaceuticals Incorporated $VRTX](https://longbridge.com/en/news/296021261.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**